Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test

By Colin KellaherTrading in shares of Grail is halted on Wednesday ahead of a Food and Drug Administration advisory committee meeting to discuss the diagnostic company's proposed multi-cancer blood test.Grail is seeking FDA approval of Galleri, a blood test that aims to catch cancers before symptom…